Follicum plans to start clinical studies during 2015. To be able to obtain the authorities’ approval for the clinical studies Follicum needs to present the results of preclinical studies, e g tox studies. In December 2014 Follicum started two smaller tox studies, which now are completed. The results are positive, showing that FOL-005 does not […]
Draft document prepared with a proposed design for the Phase I/II a-study to be used in the discussions with a medical agency. Two small toxicological studies have also been initiated.
Repeated experiment confirms positive results from ex vivo test on human skin tissue. The experiment was performed by a well-known research group in Münster, Germany.
Report for Q3 published (in Swedish). To open the document, click here.